Gary M. Ksander
Novartis (United States)(US)
Publications by Year
Research Areas
Hormonal Regulation and Hypertension, Nitric Oxide and Endothelin Effects, Pharmacogenetics and Drug Metabolism, Peptidase Inhibition and Analysis, Receptor Mechanisms and Signaling
Most-Cited Works
- → Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual‐Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi)(2009)495 cited
- → Chemie der α‐Aminonitrile 1. Mitteilung Einleitung und Wege zu Uroporphyrinogen‐octanitrilen(1987)91 cited
- → Glucocorticoid Receptor Antagonism by Cyproterone Acetate and RU486(2003)90 cited
- → Stereospecific total synthesis of aphidicolin(1979)89 cited
- → A method for the synthesis of unsaturated carbonyl compounds(1977)84 cited
- → Dicarboxylic Acid Dipeptide Neutral Endopeptidase Inhibitors(1995)81 cited
- → Structure of neprilysin in complex with the active metabolite of sacubitril(2016)67 cited
- → Ortho-Substituted Benzofused Macrocyclic Lactams as Zinc Metalloprotease Inhibitors(1997)52 cited
- → Discovery and in Vivo Evaluation of Potent Dual CYP11B2 (Aldosterone Synthase) and CYP11B1 Inhibitors(2013)46 cited
- → Total synthesis of aphidicolin(1981)42 cited